Neuroscience
A press release from the NIH:
Prescribed stimulant use for ADHD continues to rise steadily
NIH and AHRQ study finds pace of the rise has slowed in recent years
"The prescribed use of stimulant medications to treat attention deficit hyperactivity disorder (ADHD) rose slowly but steadily from 1996 to 2008, according to a study conducted by the National Institutes of Health (NIH) and the Agency for Healthcare Research and Quality (AHRQ). The study was published online ahead of print Sept. 28, 2011, in the American Journal of Psychiatry.
"ADHD is one of the most common childhood disorders, and can continue through adolescence and adulthood. Symptoms include difficulty staying focused and paying attention, difficulty controlling behavior, and hyperactivity (over-activity). The condition is frequently treated with stimulants such as methylphenidate (e.g., Ritalin), amphetamines (e.g., Adderall) or other types of medications. Behavioral therapies can also be effective.
"During the 1990s, stimulant prescription use increased significantly, going from a prevalence rate among youth of 0.6 percent in 1987 to 2.7 percent in 1997, with the rate stabilizing around 2.9 percent in 2002. Recent reports, however, suggest that the prescribed use of these medications and the diagnosis of ADHD have continued to rise. Based on the Health Resources and Services Administration’s National Survey of Children's Health, the percentage of children age 4-17 years diagnosed with ADHD increased from 7.8 percent in 2003 to 9.5 percent in 2007.
"Stimulant medications work well to control ADHD symptoms, but they are only one method of treatment for the condition. Experts estimate that about 60 percent of children with ADHD are treated with medication," said co-author Benedetto Vitiello, M.D., of NIH's National Institute of Mental Health (NIMH)."
Read the full press release
- Overmedicated, Undermedicated?
It appears to depend on who you are (and who you ask), according to two papers in the January 2010 issue of Archives of General Psychiatry. According to the press releases: More US patients receive multiple psychotropic medicationsAn increasing number...
- Daytrana (methylphenidate Patch) & Adhd
From the website of The Washington Post: FDA OKs First Attention Deficit Patch By ANDREW BRIDGES The Associated Press Thursday, April 6, 2006; 8:06 PM WASHINGTON -- The FDA on Thursday approved the first skin patch to treat attention deficit hyperactivity...
- Modafinil, Adhd, And The Fda
From The Washington Post: Use of Drug to Treat ADHD in Children Opposed Associated Press Friday, March 24, 2006; Page A11 The narcolepsy drug modafinil should not be approved as a treatment for attention-deficit hyperactivity disorder in children until...
- Methylphenidate Transdermal Patch (daytrana), Adhd, & The Fda: Thursday And Friday
THURSDAY: From The Washington Post website:Problem Found With Potential ADHD Patch The Associated Press Thursday, December 1, 2005; 3:01 PM WASHINGTON -- A patch developed to treat attention deficit hyperactivity disorder in children received a negative...
- Adhd Treatment
The full-text contents of the following article is available on the Pediatrics website at this link [Click here]: Ronald T. Brown, Robert W. Amler, Wendy S. Freeman, James M. Perrin, Martin T. Stein, Heidi M. Feldman, Karen Pierce, Mark L. Wolraich and...
Neuroscience
Prescribed Stimulant Use for ADHD Continues to Rise Steadily
A press release from the NIH:
Prescribed stimulant use for ADHD continues to rise steadily
NIH and AHRQ study finds pace of the rise has slowed in recent years
"The prescribed use of stimulant medications to treat attention deficit hyperactivity disorder (ADHD) rose slowly but steadily from 1996 to 2008, according to a study conducted by the National Institutes of Health (NIH) and the Agency for Healthcare Research and Quality (AHRQ). The study was published online ahead of print Sept. 28, 2011, in the American Journal of Psychiatry.
"ADHD is one of the most common childhood disorders, and can continue through adolescence and adulthood. Symptoms include difficulty staying focused and paying attention, difficulty controlling behavior, and hyperactivity (over-activity). The condition is frequently treated with stimulants such as methylphenidate (e.g., Ritalin), amphetamines (e.g., Adderall) or other types of medications. Behavioral therapies can also be effective.
"During the 1990s, stimulant prescription use increased significantly, going from a prevalence rate among youth of 0.6 percent in 1987 to 2.7 percent in 1997, with the rate stabilizing around 2.9 percent in 2002. Recent reports, however, suggest that the prescribed use of these medications and the diagnosis of ADHD have continued to rise. Based on the Health Resources and Services Administration’s National Survey of Children's Health, the percentage of children age 4-17 years diagnosed with ADHD increased from 7.8 percent in 2003 to 9.5 percent in 2007.
"Stimulant medications work well to control ADHD symptoms, but they are only one method of treatment for the condition. Experts estimate that about 60 percent of children with ADHD are treated with medication," said co-author Benedetto Vitiello, M.D., of NIH's National Institute of Mental Health (NIMH)."
Read the full press release
- Overmedicated, Undermedicated?
It appears to depend on who you are (and who you ask), according to two papers in the January 2010 issue of Archives of General Psychiatry. According to the press releases: More US patients receive multiple psychotropic medicationsAn increasing number...
- Daytrana (methylphenidate Patch) & Adhd
From the website of The Washington Post: FDA OKs First Attention Deficit Patch By ANDREW BRIDGES The Associated Press Thursday, April 6, 2006; 8:06 PM WASHINGTON -- The FDA on Thursday approved the first skin patch to treat attention deficit hyperactivity...
- Modafinil, Adhd, And The Fda
From The Washington Post: Use of Drug to Treat ADHD in Children Opposed Associated Press Friday, March 24, 2006; Page A11 The narcolepsy drug modafinil should not be approved as a treatment for attention-deficit hyperactivity disorder in children until...
- Methylphenidate Transdermal Patch (daytrana), Adhd, & The Fda: Thursday And Friday
THURSDAY: From The Washington Post website:Problem Found With Potential ADHD Patch The Associated Press Thursday, December 1, 2005; 3:01 PM WASHINGTON -- A patch developed to treat attention deficit hyperactivity disorder in children received a negative...
- Adhd Treatment
The full-text contents of the following article is available on the Pediatrics website at this link [Click here]: Ronald T. Brown, Robert W. Amler, Wendy S. Freeman, James M. Perrin, Martin T. Stein, Heidi M. Feldman, Karen Pierce, Mark L. Wolraich and...